Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Clinical aspect
Year range
1.
Journal de chirurgie viscerale ; 157(3):S6-S12, 2020.
Article | WHO COVID | ID: covidwho-728654

ABSTRACT

The COVID-19 pandemic is changing the organization of healthcare and has a direct impact on digestive surgery Healthcare priorities and circuits are being modified Emergency surgery is still a priority Functional surgery is to be deferred Laparoscopic surgery must follow strict rules so as not to expose healthcare professionals (HCPs) to added risk The question looms large in cancer surgery - go ahead or defer? There is probably an added risk due to the pandemic that must be balanced against the risk incurred by deferring surgery For each type of cancer - colon, pancreas, oesogastric, hepatocellular carcinoma - morbidity and mortality rates are stated and compared with the oncological risk incurred by deferring surgery and/or the tumour doubling time Strategies can be proposed based on this comparison For colonic cancers T1-2, N0, it is advisable to defer surgery For advanced colonic lesions, it seems judicious to undertake neoadjuvant chemotherapy and then wait For rectal cancers T3-4 and /or N+, chemoradiotherapy is indicated, short radiotherapy must be discussed (followed by a waiting period) to reduce time of exposure in the hospital and to prevent infections Most complex surgery with high morbidity and mortality - oesogastric, hepatic or pancreatic - is most often best deferred

3.
J Visc Surg ; 157(3S1): S7-S12, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-39755

ABSTRACT

The Covid-19 pandemic is changing the organization of healthcare and has a direct impact on digestive surgery. Healthcare priorities and circuits are being modified. Emergency surgery is still a priority. Functional surgery is to be deferred. Laparoscopic surgery must follow strict rules so as not to expose healthcare professionals (HCPs) to added risk. The question looms large in cancer surgery-go ahead or defer? There is probably an added risk due to the pandemic that must be balanced against the risk incurred by deferring surgery. For each type of cancer-colon, pancreas, oesogastric, hepatocellular carcinoma-morbidity and mortality rates are stated and compared with the oncological risk incurred by deferring surgery and/or the tumour doubling time. Strategies can be proposed based on this comparison. For colonic cancers T1-2, N0, it is advisable to defer surgery. For advanced colonic lesions, it seems judicious to undertake neoadjuvant chemotherapy and then wait. For rectal cancers T3-4 and/or N+, chemoradiotherapy is indicated, short radiotherapy must be discussed (followed by a waiting period) to reduce time of exposure in the hospital and to prevent infections. Most complex surgery with high morbidity and mortality-oesogastric, hepatic or pancreatic-is most often best deferred.


Subject(s)
Coronavirus Infections , Digestive System Diseases/surgery , Digestive System Neoplasms/surgery , Pandemics , Pneumonia, Viral , Health Services Needs and Demand , Humans , Laparoscopy , Postoperative Care , Practice Guidelines as Topic , Time-to-Treatment
SELECTION OF CITATIONS
SEARCH DETAIL